Related Experiment Video
Updated: Oct 18, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Mucormycosis in CAPA, a Possible Fungal Super-Infection
Paola Saltini1,2,3, Emanuele Palomba1,2,3, Valeria Castelli1,2,3
1Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
Abstract:
The occurrence of pulmonary fungal superinfection due to Aspergillus spp. in patients with COVID-19 is a well-described complication associated with significant morbidity and mortality. This can be related to a directed effect of the virus and to the immunosuppressive role of the therapies administered for the disease. Here, we describe the first case of pulmonary infection due to Mucorales occurring in a patient with a concomitant diagnosis of COVID-19-associated pulmonary aspergillosis.
Insights
Pulmonary fungal superinfections, like aspergillosis, are known complications in COVID-19 patients. This study reports the first case of Mucorales infection alongside COVID-19-associated pulmonary aspergillosis.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- COVID-19 can lead to pulmonary fungal superinfections, notably by Aspergillus spp.
- These infections increase morbidity and mortality in patients with COVID-19.
- Therapies for COVID-19 can also contribute to immunosuppression, increasing infection risk.
Observation:
- This report details a unique case of a patient with COVID-19.
- The patient presented with a concurrent diagnosis of COVID-19-associated pulmonary aspergillosis.
- Additionally, the patient developed a pulmonary infection caused by Mucorales.
Findings:
- This is the first documented case of pulmonary Mucorales infection in a patient with COVID-19-associated pulmonary aspergillosis.
- The co-occurrence of these two distinct fungal infections is a significant clinical observation.
Implications:
- This case highlights the potential for multiple, concurrent fungal infections in severe COVID-19.
- It underscores the need for heightened vigilance and diagnostic consideration for various fungal pathogens.
- Further research is warranted to understand the mechanisms and management of such co-infections.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Pneumonia II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment

